ArticleJournal of inorganic biochemistry2026
The role of conserved elements in an active site α-helix of coproheme decarboxylase.
Article in Journal of inorganic biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The final step in the coproporphyrin-dependent (CPD) branch of the heme biosynthesis pathway involves the oxidative decarboxylation of coproheme to form heme b. This reaction, catalyzed by coproheme decarboxylase (ChdC), requires two equivalents of hydrogen peroxide to complete the synthesis of one b-type heme molecule. The CPD pathway is limited to Gram-positive bacteria and some archaea, and the precise mechanism of ChdC differs between Firmicutes and Actinobacteria. These variations highlight the importance of studying ChdCs from diverse organisms. The reaction proceeds through two sequential oxidative decarboxylations via the intermediate monovinyl monopropionate deuteroheme (MMD). Previous studies suggest that MMD does not exit the active site but instead undergoes a 90-degree rotation before another equivalent of hydrogen peroxide binds and initiates the second oxidative decarboxylation. This mechanism requires a high degree of specificity to distinguish between substrate, intermediate, and final product. To further understand this selectivity, we present biochemical and structural analyses of wild-type and variant forms of ChdC from Streptomyces coelicolor (ScChdC). We hypothesize that a conserved active site element within an alpha helix contributes to porphyrin specificity/selectivity and conformation and investigate how this influences an active site loop. Our data provides new insight into the role of this loop in substrate recognition, rotation, and catalysis. The substrate selectivity model for ChdC developed in this study will inform future mechanistic investigations and provide insights into key functional interfaces, highlighting potential targets for drug development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.